424 related articles for article (PubMed ID: 25392292)
1. Use of synthetic cannabinoids in patients with psychotic disorders: case series.
Celofiga A; Koprivsek J; Klavz J
J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
4. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
[TBL] [Abstract][Full Text] [Related]
5. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
7. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
8. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
Schwarcz G; Karajgi B; McCarthy R
J Clin Psychopharmacol; 2009 Jun; 29(3):255-8. PubMed ID: 19440079
[TBL] [Abstract][Full Text] [Related]
9. JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up.
Coppola M; Mondola R
J Psychoactive Drugs; 2017; 49(3):262-265. PubMed ID: 28441106
[TBL] [Abstract][Full Text] [Related]
10. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
[TBL] [Abstract][Full Text] [Related]
11. Toxicological findings of synthetic cannabinoids in recreational users.
Kronstrand R; Roman M; Andersson M; Eklund A
J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
[TBL] [Abstract][Full Text] [Related]
12. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
Zaitsu K; Nakayama H; Yamanaka M; Hisatsune K; Taki K; Asano T; Kamata T; Katagai M; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A
Int J Legal Med; 2015 Nov; 129(6):1233-45. PubMed ID: 26349566
[TBL] [Abstract][Full Text] [Related]
13. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabis.
Westin AA; Brede WR; Espnes KA
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
[No Abstract] [Full Text] [Related]
15. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
[TBL] [Abstract][Full Text] [Related]
16. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
Skryabin VY; Vinnikova MA
J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
[TBL] [Abstract][Full Text] [Related]
17. Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.
Szily E; Bitter I
Neuropsychopharmacol Hung; 2013 Dec; 15(4):223-31. PubMed ID: 24380963
[TBL] [Abstract][Full Text] [Related]
18. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.
Cooper ZD; Poklis JL; Liu F
Neuropharmacology; 2018 May; 134(Pt A):92-100. PubMed ID: 29146503
[TBL] [Abstract][Full Text] [Related]
19. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
20. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
